BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1325506)

  • 21. Cardiac polyamine metabolism in spontaneously hypertensive rats: effect of antihypertensive treatment.
    Ruskoaho H; Raunio H
    J Hypertens Suppl; 1986 Dec; 4(6):S71-4. PubMed ID: 3475431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of sodium in modulation of myocardial hypertrophy in renal hypertensive rats.
    Sen S; Young DR
    Hypertension; 1986 Oct; 8(10):918-24. PubMed ID: 2944827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aging and isomyosin pattern of the left ventricle in spontaneously hypertensive and Wistar Kyoto rats].
    Vulpis V; Ricci S; Seccia TM; Lograno M; Daniele E; Pirrelli A
    Cardiologia; 1996 Sep; 41(9):877-82. PubMed ID: 8983844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered inotropic responsiveness and gene expression of hypertrophied myocardium with captopril.
    Brooks WW; Bing OH; Boluyt MO; Malhotra A; Morgan JP; Satoh N; Colucci WS; Conrad CH
    Hypertension; 2000 Jun; 35(6):1203-9. PubMed ID: 10856264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in cardiac myosin isozymes associated with aging and chronic hypertension: their modulation with nifedipine.
    Raizada V; Pathak D; Blomquist TM; Minser R; Woodfin B
    Cardiovasc Res; 1993 Oct; 27(10):1869-72. PubMed ID: 8275537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regression of cardiac hypertrophy after therapy in animal hypertension.
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S56-61. PubMed ID: 2409372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catecholamines, blood pressure, renin and myocardial function in the spontaneously hypertensive rat.
    Oparil S; Erinoff L; Cutilletta A
    Clin Sci Mol Med Suppl; 1976 Dec; 3():445s-459s. PubMed ID: 140036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Losartan inhibits myosin isoform shift after myocardial infarction in rats.
    Zhang ML; Elkassem S; Davidoff AW; Saito K; ter Keurs HE
    Mol Cell Biochem; 2003 Sep; 251(1-2):111-7. PubMed ID: 14575312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of long-term arotinolol treatment on myocardial mechanics and ventricular myosin isoenzymes in spontaneously hypertensive rats.
    Takeda N; Ohkubo T; Iwai T; Tanamura A; Nagano M
    Arch Int Pharmacodyn Ther; 1990; 305():63-8. PubMed ID: 1700686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in myosin isozyme distribution induced by low doses of isoproterenol.
    Sreter FA; Faris R; Balogh I; Somogyi E; Sotonyi P
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):159-64. PubMed ID: 6219644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of regression of cardiac hypertrophy on ischemic myocardial damage in spontaneously hypertensive rats.
    Okamoto K; Abe M; Haneda T
    Jpn Circ J; 1993 Feb; 57(2):147-60. PubMed ID: 8450599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of long term treatment with an alpha 1 adrenoceptor blocker on cardiac hypertrophy, contractility, and myosin isoenzymes in spontaneously hypertensive rats.
    Takeda N; Nakamura I; Ohkubo T; Iwai T; Tanamura A; Nagano M
    Cardiovasc Res; 1991 Jul; 25(7):565-7. PubMed ID: 1680560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular manifestations of cardiac hypertrophy in the spontaneously hypertensive rat effects of antihypertensive treatments.
    Kessler-Icekson G; Barhum Y; Schlesinger H; Shohat J; Sharma H; Schaper W
    Adv Exp Med Biol; 1995; 382():195-203. PubMed ID: 8540396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial contractility and energetics in cardiac hypertrophy and its regression.
    Takeda N; Iwai T; Tanamura A; Nakamura I; Ohkubo T; Nagano M
    Mol Cell Biochem; 1993 Dec; 129(2):133-8. PubMed ID: 8177235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial response to stress in cardiac hypertrophy and heart failure: effect of antihypertensive drugs.
    Sen S
    Ann N Y Acad Sci; 1999 Jun; 874():125-33. PubMed ID: 10415526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regression of cardiac hypertrophy. Experimental animal model.
    Sen S
    Am J Med; 1983 Sep; 75(3A):87-93. PubMed ID: 6137950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diltiazem prevents hypertrophy progression, preserves systolic function, and normalises myocardial oxygen utilisation in the spontaneously hypertensive rat.
    Tubau JF; Wikman-Coffelt J; Massie BM; Szlachcic J; Parmley WW; Sievers R; Henderson S
    Cardiovasc Res; 1987 Aug; 21(8):606-14. PubMed ID: 2965615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal polyamine metabolism in hypertensive cardiac hypertrophy.
    Shimizu M; Masuda I; Aihara K; Nakano T; Ogawa K; Mizokami T; Irimajiri O; Taniguchi I; Ozasa H; Kageyama S
    Jpn Circ J; 1988 Oct; 52(10):1209-15. PubMed ID: 2974893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contractile function, myosin ATPase activity and isozymes in the hypertrophied pig left ventricle after a chronic progressive pressure overload.
    Wisenbaugh T; Allen P; Cooper G; Holzgrefe H; Beller G; Carabello B
    Circ Res; 1983 Sep; 53(3):332-41. PubMed ID: 6224606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of long-term treatment with beta-blocker on cardiac hypertrophy in SHR.
    Ieki K; Yazaki Y; Yamaoki K; Tsuchimochi H; Yoshizumi M; Komuro I; Sugiyama T; Seko Y; Takaku F; Kojima M
    J Mol Cell Cardiol; 1989 Dec; 21 Suppl 5():113-9. PubMed ID: 2576458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.